ean Bosco Kasiam Lasi ON KIN, Benjamin LONGO MBENZA, Venant TCHOKONTE NANA, Augustin Nge OKWE, Nelly Kangola KABANGU

Hyperbolic relation between beta-cell function and insulin sensitivity for type 2 diabetes mellitus, malaria, influenza, Helicobacter pylori, Chlamydia pneumoniae, and hepatitis C virus infection-induced inflammation/oxidative stress and temporary insulin resistance in Central Africans

Background/aim: We calculated the homeostatic model assessment (HOMA) for estimating insulin sensitivity and beta-cell function in normal, healthy nondiabetics with infections (malaria, influenza, HIV, Helicobacter pylori, Chlamydia pneumoniae, and hepatitis C virus), type 2 diabetic black patients, and healthy controls from Kinshasa, DR Congo. Materials and methods: A case-control study was carried out between 2006 and 2007 for black Central African participants managed for HOMA. Results: In total, 219 patients and 110 healthy controls were matched for sex and age. The hyperbolic product for 85 infected patients occupied an intermediate position between the hyperbolic product for 110 controls and that of 134 type 2 diabetics. Inflammation/ oxidative stress was present in all infected patients, as well as in the type 2 diabetics. Of the patients, 39.3% and 49.8% had insulin resistance and metabolic syndrome, respectively. Insulin resistance was more prevalent in nondiabetics with inflammation/oxidative stress (47.1%; P = 0.041) than in type 2 diabetics (34.3%). Type 2 diabetics had higher insulin sensitivity and lower beta-cell function but a similar HOMA-IR score. Conclusion: We recommend the assessment of insulin resistance in Central African patients with severe infections and type 2 diabetes.

PDF

___

1. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni TI, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.
2. Bergman RN, Watanabe R, Rebrin K, Ader M, Steil G. Toward an integrated phenotype in pre-NIDDM. Diabetic Med 1996; 13: S67-S77.
3. Bergman RN. Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology. Mt Sinai J Med 2002; 69: 280-290.
4. Guerrero-Romero F, Rodríguez-Morán M. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus. Eur J Clin Invest 2006; 36: 796-802.
5. Hermans MP. Diabetic macro-and microvascular disease in type 2 diabetes. Diab Vasc Dis Res 2007; 4: S7-S11.
6. Hermans M. Comment mesurer et interpréter en pratique la mesure combinée de la sensibilité a linsuline et de la fonction sécrétoire β? Louvain Med 2006; 125: S82-S89 (in French).
7. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106: 473-481.
8. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 42: 1663-1672.
9. Preumont V, Hermans MP, Lebecque P, Buysschaert M. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene ΔF508 mutation. Diabetes Care 2007; 30: 1187-1192.
10. Pacini G. The hyperbolic equilibrium between insulin sensitivity and secretion. Nutr Metab Cardiovas 2006; 16: S22-S27.
11. Mantzoros CS, Flier JS. Insulin resistance: the clinical spectrum. Therapeutic Advances in Endocrinology Metabolism 1995; 6: 193-232.
12. Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059.
13. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, Morris R, Zavaroni I, van Dam R, Feskins E et al. European Group for the Study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364-376.
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26: S5-S20.
15. Le Roith D, Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 2001; 24: 588-597.
16. Moller DE, Flier JS. Insulin resistancemechanisms, syndromes, and implications. N Engl J Med 1991; 325: 938-948.
17. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
18. Reilly M, Rader D. The metabolic syndrome: more than the sum of its parts? Circulation 2003; 108: 1546-1551.
19. Barzilay JI, Blaum C, Moore T, Xue QL, Hirsch CH, Walston JD, Fried LP. Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med 2007; 167: 635-641.
20. Fernandez-Real JM, Lopez-Bermejo A, Vendrell J, Ferri MJ, Recasens M, Ricart W. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care 2006; 29: 1058-1064.
21. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003; 52: 1799-1805.
22. Tataranni PA, Ortega E. A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes 2005; 54: 917-927.
23. Estein S, Zhou Y, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999; 100: e20-e28.
24. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 2002; 106: 184- 190.
25. Longokolo MM. HIV/AIDS and metabolic syndrome in Kinshasa hospitals. PhD, University of Kinshasa, Kinshasa, Democratic Republic of the Congo, 2008.
26. Longo-Mbenza B, Nkondi Mbadi A, Mbungu Fuele S. Higher pulse pressure, systolic arterial hypertension, duration of diabetes and family history of diabetes in Central Africans. International Journal of Diabetes & Metabolism 2008; 16: 17- 23.
27. Longo-Mbenza B, Tonduangu K, Kintonki Vita E, Seghers KV. The effect of HIV infection on high incidence of heart diseases in Kinshasa (Zaire). Echocardiographic study. Ann Cardiol Angeiol 1997; 46: 81-87.
28. Longo-Mbenza B, Phanzu-Mbete LB, MBuyamba-Kabangu JR, Tonduangu K, Mvunzu M, Muvova D, Lukoki-Luila E, Bayekula M, Odio W, Kintoki V et al. Hematocrit and stroke in black Africans under tropical climate and meteorological influence. Ann Med Interne 1999; 150: 171-177.
29. Long-Mbenza B, Manbune HE, Kasiam JB, Vita EK, Fuele SM, Nsenga JN, Mabwa L, Nzuzi V. Relationship between waist circumference and cholesterol in Central Africans with congestive heart failure. West African Journal of Medicine 2007; 26: 183-190.
30. Manuthu EM, Joshi M, Lule G, Karari E. Prevalence of dyslipidemia and dysglycaemia in HIV infected patients. E Afr Med J 2008; 85: 10.
31. Nsenga JN, Longo-Mbenza B, Mpolesha JK, Mabwa L, Mbungu S, Vangu D. Séropositivité pour Helicobacter pylori, gastrite à Helicobacter pylori, composantes de la pression artérielle: réalité du risque cardiovasculaire. Journal Africain dHépatoGastroentérologie 2007; 1: 87-92 (in French).
32. Dehout F, Haumont S, Gaham N, Amoussou-Guenou KD, Hermans MP. Metabolic syndrome in Bantu subjects with type 2 diabetes from sub-Saharan extraction: prevalence, gender differences and HOMA hyperbolic product. Diabetes & Metabolic Syndrome 2008; 2: 5-11.
33. Longo-Mbenza B, Luila EL, Mbete P, Vita EK. Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans? Int J Cardiol 1999; 71: 17-22.
34. Longo-Mbenza B, Ngoma DV, Nahimana D, Mayuku DM, Fuele SM, Ekwanzala F, Beya C. Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa. Eur J Cardiov Prev R 2008; 15: 503-508.
35. Longo-Mbenza B, Tonduangu K, Muyeno K, Phanzu M, Kebolo BA, Muvova D, Lelo T, Odio W, Lukoki L, Bikangi NF et al. Predictors of stroke-associated mortality in Africans. Rev Epidemiol Sante 2000; 48: 31-39.
36. Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab 2001; 27: 628-634.
37. Sumner AE, Vega GL, Genovese DJ, Finley KB, Bergman RN, Boston RC. Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism 2005; 54: 902-909.
38. Longo-Mbenza B, Nsenga JN, Ngoma DV. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol 2007; 121: 229-238.
39. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
40. Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, Tahara H, Koyama H, Shoji T, Inaba M et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. J Clin Endocr Metab 2004; 89: 1481- 1484.
41. Fezeu L, Balkau B, Kengne A, Sobngwi E, Mbanya J. Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. Atherosclerosis 2007; 193: 70-76.
42. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA-J Am Med Assos 2002; 287: 356-359.
43. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, Whelton PK, He J; InterASIA Collaborative Group. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365: 1398-1405.
44. Meigs JB, Nathan DM, Wilson PW, Cupples LA, Singer DE. Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance: the Framingham Offspring Study. Ann Intern Med 1998; 128: 524-533.
45. OnKin JKL, Longo-Mbenza B, Okwe AN, Kabangu NK. Survey of abdominal obesities in an adult urban population of Kinshasa, Democratic Republic of Congo: cardiovascular topics. Cardiovasc J Afr 2007; 18: 300-307.